These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 3887213)
1. Long-term experience with pergolide therapy of advanced parkinsonism. Kurlan R; Miller C; Levy R; Macik B; Hamill R; Shoulson I Neurology; 1985 May; 35(5):738-42. PubMed ID: 3887213 [TBL] [Abstract][Full Text] [Related]
2. Long-term efficacy of pergolide in patients with Parkinson's disease. Sage JI; Duvoisin RC Clin Neuropharmacol; 1986; 9(2):160-4. PubMed ID: 3708601 [TBL] [Abstract][Full Text] [Related]
3. [Clinical study of pergolide in Parkinson's disease]. Gonce M; Delwaide PJ Presse Med; 1985 Jun; 14(26):1409-11. PubMed ID: 3161045 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of pergolide and mesulergine. Lieberman AN; Gopinathan G; Neophytides A Eur Neurol; 1986; 25(2):86-90. PubMed ID: 3948891 [TBL] [Abstract][Full Text] [Related]
5. Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolide. Goetz CG; Tanner CM; Glantz RH; Klawans HL Neurology; 1985 May; 35(5):749-51. PubMed ID: 3990974 [TBL] [Abstract][Full Text] [Related]
6. Controlled trial of pergolide mesylate in Parkinson's disease and progressive supranuclear palsy. Jankovic J Neurology; 1983 Apr; 33(4):505-7. PubMed ID: 6339985 [TBL] [Abstract][Full Text] [Related]
7. The use of pergolide, a potent dopamine agonist, in Parkinson's disease. Lieberman AN; Goldstein M; Neophytides A; Leibowitz M; Gopinathan G; Walker R; Pact V Clin Pharmacol Ther; 1982 Jul; 32(1):70-5. PubMed ID: 7083733 [TBL] [Abstract][Full Text] [Related]
8. Pergolide and lisuride in advanced Parkinson's disease. Lieberman AN; Gopinathan G; Neophytides A; Leibowitz M; Goldstein M Adv Neurol; 1984; 40():503-7. PubMed ID: 6695627 [TBL] [Abstract][Full Text] [Related]
10. Suppression of REM rebound by Pergolide. Askenasy JJ; Yahr MD J Neural Transm; 1984; 59(2):151-9. PubMed ID: 6726217 [TBL] [Abstract][Full Text] [Related]
11. The use of pergolide and lisuride, two experimental dopamine agonists, in patients with advanced Parkinson disease. Lieberman AN; Leibowitz M; Gopinathan G; Walker R; Hiesiger E; Nelson J; Goldstein M Am J Med Sci; 1985 Sep; 290(3):102-6. PubMed ID: 4050844 [TBL] [Abstract][Full Text] [Related]
12. Further studies with pergolide in Parkinson disease. Lieberman AN; Goldstein M; Gopinathan G; Leibowitz M; Neophytides A; Walker R; Hiesiger E; Nelson J Neurology; 1982 Oct; 32(10):1181-4. PubMed ID: 6889703 [TBL] [Abstract][Full Text] [Related]